NCT06806787|Recruiting
Loading search results
Sponsor study identifier
observational
30
1 country
1
Study Start
September 13, 2023
Actual (reported)Primary Completion
March 13, 2026
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
March 14, 2026
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Prospective, non-pharmacological, spontaneous, single-center, interventional study.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
March 14, 2026
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
September 13, 2023
Actual (reported)December 30, 2024
Actual (reported)February 4, 2025
Actual (reported)March 13, 2026
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
March 14, 2026
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Postoperative Weight Loss and Copeptin Concentration Association
To verify the existence of an association between postoperative weight loss and reduced copeptin concentration in patients with obesity undergoing laparoscopic sleeve gastrectomy surgery.
through study completion, an average of 1 year
Correlation Between Copeptin Concentration and Thirst Perception
To verify the degree of correlation between copeptin concentration and thirst perception in patients with obesity undergoing laparoscopic sleeve gastrectomy surgery.
through study completion, an average of 1 year
Association Between Reduced Copeptin Concentration and Metabolic Parameters (Fasting Glucose, Insulin, HOMA-IR, Lipid Profile, HbA1c) in Patients Undergoing Laparoscopic Sleeve Gastrectomy
through study completion, an average of 1 year
Correlation Between Thirst Perception (Assessed by a Validated Scale) and Metabolic Parameters (Fasting Glucose, Insulin, HOMA-IR, Lipid Profile, HbA1c) in Patients Undergoing Laparoscopic Sleeve Gastrectomy
through study completion, an average of 1 year
COPTBAR is a prospective, nonpharmacological spontaneous single-center interventional study. Laboratory tests and imaging study (complete abdomen ultrasonography) for monitoring patients will be conducted in accordance with normal clinical practice. In addition, periodic copeptin assay will be performed. Each patient, within the study protocol, will be evaluated for 12 months; thereafter, each patient will fall under the follow-up visits provided by normal clinical practice and by Corporate Diagnostic Therapeutic Pathway (PDTA).
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Bologna, Bologna, 40138, Italy
Uberto Pagotto, MD
IRCCS Azienda Ospedaliero-Universitaria di Bologna
First Submitted
December 30, 2024
First Posted
February 4, 2025
Study Start
September 13, 2023
Actual (reported)Primary Completion
March 13, 2026
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Promoting Positive Mental Health for Sustainable Eating Behaviors
Contact the study team to confirm eligibility.
Study Completion
March 14, 2026
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Last Updated
February 4, 2025
Record last verified: 2024-12
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: